Skip to content

Baudax Bio nabs purchasing agreement with Premier for ANJESO

August 25, 2020

Baudax Bio (NASDAQ:BXRX) +10% AH, is awarded a group purchasing agreement with Premier, effective August 2020, enabling Premier members, at their discretion, to take advantage of special pricing and terms pre-negotiated by the latter for ANJESO (meloxicam) injection.

The drug is for the management of moderate to severe pain, alone or in combination with other non-NSAID analgesics.

From → Uncategorized

Leave a Comment

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

%d bloggers like this: